FTRE · Fortrea Holdings Inc. · Metrics
$24.12
+1.34 (+5.88%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.17B
Shares
95.10M
Volume · Oct 21
1.53M
Avg daily vol (3M)
1.59M
FTRE metrics
77 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$22.78
Market cap
$2.17B
Price action
20 metricsPrice change (1W)
+8.9%
Price change (30D)
+13.8%
Price change (3M)
+27.2%
Price change (6M)
+120.7%
Price change (YTD)
+32.1%
Price change (1Y)
+118.6%
Trailing year
Price change (5Y)
—
52-week high
$22.78
52-week low
$8.87
Change from 52-week high
+0.0%
Change from 52-week low
+156.8%
Annualized volatility
70.9%
Annualized volatility (3M)
55.4%
Beta
1.9
RSI (14D)
69.4
Price vs SMA 50
+17.6%
Price vs SMA 200
+47.5%
Avg volume (3M)
1.59M
Relative volume
1.5
Average dollar volume
$31.10M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
95.10M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 87.7%
EV / EBITDA
45.2×
reciprocal yield 2.2%
EV / EBIT
—
P / sales
0.8×
reciprocal yield 123.5%
P / book
4.1
reciprocal yield 24.2%
FCF yield
9.0%
TTM · current market cap
Buyback yield
—
P / FCF
11.1
reciprocal yield 9.0%
P / operating cash flow
9.5
reciprocal yield 10.5%
Earnings yield
-3.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 113.6%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 113.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-29
Profitability
9 metricsGross margin
—
Operating margin
-0.4%
Trailing 12 months
Net margin
-3.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$10.80M
Net income (TTM)
−$85.20M
Trailing 12 months
Diluted EPS (TTM)
$-0.81
FCF margin
7.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-4.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.68B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.6%
Year over year · more shares
Revenue CAGR (3Y)
-1.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+46.1%
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-16.3%
Return on assets
-3.1%
Debt / equity
2.0
Current ratio
1.0
EBITDA (TTM)
$67.50M
Free cash flow (TTM)
$196.00M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
13.1
Return on invested capital
—
Trailing 12 months
Net cash
−$885.70M
Latest balance sheet
Cash & equivalents
$168.60M
Total assets
$2.71B
Total debt
$1.05B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$227.80M
Capital expenditures (TTM)
$31.80M
R&D (TTM)
—
SG&A (TTM)
$412.40M
Stock compensation (TTM)
$61.10M
R&D / revenue
—
Stock compensation / revenue
2.3%
Ownership (13F)
9 metrics13F filers
338
13F filer change QoQ
+4
Institutional ownership
105.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-2.3%
Holder tenure
8.5
Price vs estimated holder cost
+3.8%
Ownership (registered funds)
1 metricsIndex-fund ownership
28.8%
Short interest
3 metricsShort interest
13.2%
Latest settlement · 7.8 days to cover
Days to cover
7.8d
Short-squeeze score
77 / 100
Insider activity
2 metricsNet insider buying (90D)
−$4.26M
Insider-sentiment score
11 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1965040
CUSIP
34965K107
13F (30d)
34 filings
34 filers
Visit website
Investor relations